Elicio Therapeutics, Inc. financial data

Symbol
ELTX on Nasdaq
Location
451 D Street, 5 Th Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 218 % +3.7%
Debt-to-equity 3.42K %
Return On Equity -5.66K % -233%
Return On Assets -161 % +9.29%
Operating Margin -2.61K % -2183%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.5M shares +62.1%
Common Stock, Shares, Outstanding 17.3M shares +60%
Entity Public Float 33.2M USD -29.5%
Common Stock, Value, Issued 173K USD +60.2%
Weighted Average Number of Shares Outstanding, Basic 16.7M shares +22.9%
Weighted Average Number of Shares Outstanding, Diluted 16.7M shares +22.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 653K USD -97.8%
Research and Development Expense 30.5M USD +4.91%
General and Administrative Expense 11.8M USD +0.17%
Costs and Expenses 42.3M USD +3.54%
Operating Income (Loss) -42.3M USD -3.54%
Nonoperating Income (Expense) -3.51M USD +41%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -45.9M USD +2.11%
Earnings Per Share, Basic -3 USD/shares -117%
Earnings Per Share, Diluted -3 USD/shares -117%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.6M USD -20.8%
Other Assets, Current 405K USD -12%
Assets, Current 21.5M USD -30%
Property, Plant and Equipment, Net 328K USD -37.3%
Operating Lease, Right-of-Use Asset 5.02M USD -15.3%
Other Assets, Noncurrent 864K USD +1008%
Assets 28.3M USD -26.3%
Accounts Payable, Current 321K USD -83.8%
Employee-related Liabilities, Current 1.69M USD +14.7%
Accrued Liabilities, Current 5.21M USD +7.44%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 6.52M USD -27.8%
Operating Lease, Liability, Noncurrent 4.36M USD -18.4%
Liabilities 24.5M USD -57.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -31K USD +84.7%
Retained Earnings (Accumulated Deficit) -226M USD -25.5%
Stockholders' Equity Attributable to Parent 3.82M USD
Liabilities and Equity 28.3M USD -26.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.1M USD +16.5%
Net Cash Provided by (Used in) Financing Activities 10.3M USD -6.31%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 17.3M shares +60%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 240K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.3M USD -24%
Deferred Tax Assets, Valuation Allowance 100M USD +11.1%
Operating Lease, Liability 5.34M USD -14.1%
Depreciation 392K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -45.7M USD +2.84%
Lessee, Operating Lease, Liability, to be Paid 6.38M USD -17.4%
Property, Plant and Equipment, Gross 2.04M USD +2.26%
Operating Lease, Liability, Current 981K USD +11.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.43M USD +3.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.38M USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.04M USD -30.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.47M USD +2.95%
Deferred Tax Assets, Operating Loss Carryforwards 64.6M USD +6.51%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.1M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.51M USD +3.07%
Operating Lease, Payments 334K USD -11.9%
Additional Paid in Capital 230M USD +42.4%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.39M USD +80.3%
Interest Expense 753K USD -89.5%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%